Improving outcomes with bivalirudin in primary percutaneous coronary intervention

被引：0
|
作者：
Stone, Gregg W. [1 ,2 ]
机构：
[1] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA
[2] Cardiovasc Res Fdn, New York, NY USA
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷 / 34期
关键词：
ELEVATION MYOCARDIAL-INFARCTION; GLYCOPROTEIN IIB/IIIA INHIBITOR; STENT THROMBOSIS; CLOPIDOGREL PRETREATMENT; HEPARIN MONOTHERAPY; CLINICAL-OUTCOMES; PRIMARY PCI; ABCIXIMAB; THERAPY; METAANALYSIS;
D O I：
10.1093/eurheartj/ehu227
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2269 / 2272
页数：4
相关论文
共 50 条
  • [21] Bivalirudin in acute coronary syndrome's and percutaneous coronary intervention
    Lee, Michael S.
    Makkar, Rajendra R.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2006, 7 : S27 - S34
  • [22] The clinical and economic impact of bivalirudin for percutaneous coronary intervention
    Malik, Nikesh
    Gershlick, Anthony H.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (06) : 699 - 706
  • [23] Bivalirudin in percutaneous coronary intervention: The EUROpean BiValIrudin UtiliSatION in Practice (EUROVISION) Registry
    Hamon, Martial
    Nienaber, Christopher A.
    Galli, Stefano
    Huber, Kurt
    Lipiecki, Janusz
    Hill, JonathanM.
    Amabile, Nicolas
    Bernstein, Debra
    Deliargyris, Efthymios
    Lafont, Antoine
    Steg, Philippe Gabriel
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 173 (02) : 290 - 294
  • [24] Should bivalirudin be the anticoagulant of choice for percutaneous coronary intervention?
    Cheuk-Kit Wong
    Harvey D White
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 384 - 385
  • [25] Should bivalirudin be the anticoagulant of choice for percutaneous coronary intervention?
    Wong, CK
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (08): : 384 - 385
  • [26] Bivalirudin: role in current percutaneous coronary intervention practice
    West, N
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2005, 66 (12) : 687 - 689
  • [27] Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting
    Hobson, Alex
    Curzen, Nick
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (01) : 23 - 30
  • [28] Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
    Ramana, Ravi K.
    Lewis, Bruce E.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (03) : 493 - 505
  • [29] Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART study
    Grimfjard, Per
    Erlinge, David
    Koul, Sasha
    Lagerqvist, Bo
    Svennblad, Bodil
    Varenhorst, Christoph
    James, Stefan K.
    EUROINTERVENTION, 2017, 12 (16) : 2009 - 2017
  • [30] Safety and efficacy of switching from unfractionated heparin to bivalirudin during primary percutaneous coronary intervention
    Shah, Rahman
    Jovin, Ion S.
    Chaudhry, Amina
    Haji, Showkat A.
    Askari, Raza
    Dennis, Mallie M.
    Berzingi, Chalak
    Rao, Sunil V.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (02) : 241 - 247
12345